이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Lanka Hospitals 미래 성장

Future 기준 확인 0/6

Lanka Hospitals의 수익이 증가할 것으로 예상됨입니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Healthcare 수익 성장	17.6%
매출 성장률	11.8%
향후 자기자본 수익률	15.2%
애널리스트 커버리지	Low
마지막 업데이트	05 Mar 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

COSE:LHCL.N0000 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (LKR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	17,506	N/A	1,369	2,820	1
12/31/2025	15,578	N/A	1,126	2,191	1
12/31/2024	13,496	N/A	980	1,911	1
3/31/2024	12,828	1,478	497	1,268	N/A
12/31/2023	12,419	1,345	611	1,511	N/A
9/30/2023	11,875	757	275	1,241	N/A
6/30/2023	11,444	592	-148	651	N/A
3/31/2023	10,850	1,603	352	1,069	N/A
12/31/2022	10,698	3,247	334	804	N/A
9/30/2022	10,558	3,779	995	1,432	N/A
6/30/2022	10,678	3,826	1,713	2,067	N/A
3/31/2022	10,632	3,047	1,591	1,988	N/A
12/31/2021	10,034	2,212	1,690	2,134	N/A
9/30/2021	9,238	1,842	884	1,392	N/A
6/30/2021	8,470	1,514	1,067	1,576	N/A
3/31/2021	7,312	977	658	1,274	N/A
12/31/2020	6,804	385	202	815	N/A
9/30/2020	6,948	293	70	653	N/A
6/30/2020	6,900	350	-269	300	N/A
3/31/2020	7,361	594	198	567	N/A
12/31/2019	7,549	581	291	596	N/A
9/30/2019	7,440	714	679	940	N/A
6/30/2019	7,288	737	714	1,047	N/A
3/31/2019	7,259	817	842	1,223	N/A
12/31/2018	7,077	870	782	1,164	N/A
9/30/2018	6,862	618	640	1,046	N/A
6/30/2018	6,690	549	664	1,013	N/A
3/31/2018	6,575	563	681	961	N/A
12/31/2017	6,382	581	N/A	1,076	N/A
9/30/2017	6,304	947	N/A	1,155	N/A
6/30/2017	6,151	982	N/A	1,042	N/A
3/31/2017	6,012	991	N/A	1,103	N/A
12/31/2016	5,886	972	N/A	1,105	N/A
9/30/2016	5,763	854	N/A	1,138	N/A
6/30/2016	5,672	897	N/A	1,403	N/A
3/31/2016	5,596	889	N/A	1,354	N/A
12/31/2015	5,514	860	N/A	1,375	N/A
9/30/2015	5,360	875	N/A	1,224	N/A
6/30/2015	5,195	674	N/A	1,081	N/A
3/31/2015	4,909	529	N/A	860	N/A
12/31/2014	4,754	514	N/A	604	N/A
9/30/2014	4,518	481	N/A	637	N/A
6/30/2014	4,276	545	N/A	431	N/A
3/31/2014	4,242	646	N/A	562	N/A
12/31/2013	4,072	677	N/A	789	N/A
9/30/2013	3,893	566	N/A	633	N/A

애널리스트 미래 성장 예측

수입 대 저축률: LHCL.N0000 의 예상 수익 증가율이 절약률( 3.7% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: LHCL.N0000 의 수익이 LK 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: LHCL.N0000 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: LHCL.N0000 의 수익(연간 11.8% ) LK 시장( 15.1% 보다 느리게 성장할 것으로 예상됩니다. 15.1% 연간).

고성장 수익: LHCL.N0000 의 수익(연간 11.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: LHCL.N0000 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 15.2 %).

Lanka Hospitals 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Price target increased to LK₨101

Recent updates

New major risk - Earnings quality

The Lanka Hospitals Corporation PLC, Annual General Meeting, Jun 27, 2024

First quarter 2024 earnings released: EPS: LK₨0.32 (vs LK₨0.27 loss in 1Q 2023)

Full year 2023 earnings released: EPS: LK₨6.01 (vs LK₨14.51 in FY 2022)

The Lanka Hospitals Corporation PLC Announces Resignation of Anurag Kalra, Alternate Director to Ashish Bathia

Third quarter 2023 earnings released: EPS: LK₨2.75 (vs LK₨2.01 in 3Q 2022)

Upcoming dividend of LK₨1.50 per share at 2.8% yield

Investor sentiment improves as stock rises 15%

New major risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: LK₨0.77 (vs LK₨5.30 in 2Q 2022)

The Lanka Hospitals Corporation PLC Appoints Pattage Mayurasiri Bandula Fernando as Deputy Chairman

The Lanka Hospitals Corporation PLC, Annual General Meeting, Jun 28, 2023

First quarter 2023 earnings released: LK₨0.27 loss per share (vs LK₨7.07 profit in 1Q 2022)

Upcoming dividend of LK₨1.50 per share at 3.3% yield

Investor sentiment improves as stock rises 24%

Full year 2022 earnings released: EPS: LK₨14.51 (vs LK₨9.89 in FY 2021)

Investor sentiment improves as stock rises 16%

Third quarter 2022 earnings released: EPS: LK₨2.01 (vs LK₨2.22 in 3Q 2021)

Price target increased to LK₨101

High number of new and inexperienced directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of LK₨2.00 per share

Second quarter 2022 earnings released: EPS: LK₨5.30 (vs LK₨1.81 in 2Q 2021)

First quarter 2022 earnings released: EPS: LK₨7.07 (vs LK₨3.34 in 1Q 2021)

High number of new and inexperienced directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Now 22% undervalued

Investor sentiment improved over the past week

Upcoming dividend of LK₨1.00 per share

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS LK₨2.22 (vs LK₨0.75 in 3Q 2020)

Upcoming dividend of LK₨1.00 per share

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS LK₨1.81 (vs LK₨0.59 loss in 2Q 2020)

First quarter 2021 earnings released: EPS LK₨3.34 (vs LK₨0.69 in 1Q 2020)

New 90-day low: LK₨41.10

Full year 2020 earnings released: EPS LK₨1.72 (vs LK₨2.60 in FY 2019)

New 90-day high: LK₨53.60

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: LK₨45.00

Third quarter 2020 earnings released: EPS LK₨0.75

New 90-day high: LK₨44.20

New 90-day high - LK₨39.00

First half earnings released

The Lanka Hospitals Corporation PLC Ceases Wimal Karandagoda as Acting Group Chief Executive Officer

The Lanka Hospitals Corporation PLC Appoints Deepthi Lokuarachchi as CEO

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견